HUMHUMANA INCvs its industry peers
A metric-by-metric comparison of HUMANA INC against Health Care Select Sector SPDR Fund holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HUMEsta | $44.9B#16 | 39.9x#14 | 2.4x#2 | 0.3x#1 | 10.1%#5 | -1.6%#12 | 2.1%#16 | 6.4%#15 | 8.1%#13 | — | 52.9%#5 | 1.0%#11 |
| LLY | $1.06T#1 | 39.8x#13 | 33.8x#15 | 16.2x#16 | 44.7%#1 | 94.9%#4 | 40.2%#1 | 66.2%#2 | 30.4%#1 | — | 47.9%#6 | 0.5%#13 |
| JNJ | $613.1B#2 | 29.5x#6 | 7.2x#10 | 6.5x#12 | 6.0%#9 | 90.6%#5 | 22.9%#8 | 31.5%#7 | 16.1%#7 | 6#3 | 55.1%#3 | 2.0%#9 |
| ABBV | $433.1B#3 | 69.2x#16 | — | 7.1x#13 | 8.6%#8 | -1.2%#11 | 24.6%#7 | — | 18.6%#6 | — | 28.9%#8 | 2.7%#3 |
| MRK | $315.5B#5 | 36.0x#12 | 6.9x#8 | 4.9x#7 | 1.3%#14 | 6.6%#9 | 34.2%#3 | 39.8%#3 | 21.5%#4 | — | 65.3%#2 | 2.6%#4 |
| UNH | $377.2B#4 | 31.3x#9 | 11.4x#13 | 0.8x#2 | 11.8%#3 | -16.3%#15 | 4.2%#15 | 36.5%#4 | 19.9%#5 | — | 78.4%#1 | 2.1%#8 |
| AMGN | $204.5B#7 | 26.4x#4 | 22.2x#14 | 5.6x#10 | 10.0%#6 | 88.5%#6 | 24.7%#6 | 83.9%#1 | 15.3%#8 | — | 30.9%#7 | 2.5%#5 |
| TMO | $212.2B#6 | 30.9x#8 | 4.0x#5 | 4.8x#6 | 3.9%#11 | 6.0%#10 | 17.4%#13 | 12.8%#11 | 10.1%#11 | — | 24.4%#9 | 0.3%#14 |
| ABT | $186.6B#8 | 30.0x#7 | 3.6x#4 | 4.2x#5 | 5.7%#10 | -51.3%#16 | 18.2%#12 | 12.5%#12 | 8.3%#12 | — | -14.0%#15 | 2.2%#7 |
| GILD | $162.9B#9 | 17.9x#2 | 6.9x#9 | 5.5x#9 | 2.4%#13 | 1672.9%#1 | 34.0%#4 | 36.2%#5 | 21.6%#3 | — | 18.8%#10 | 2.5%#6 |
| ISRG | $132.6B#13 | 43.1x#15 | 7.3x#11 | 13.2x#15 | 20.5%#2 | 23.0%#7 | 29.3%#5 | 15.7%#10 | — | — | -22.3%#16 | — |
| PFE | $142.7B#10 | 19.1x#3 | 1.6x#1 | 2.3x#3 | -1.6%#16 | -3.2%#13 | 16.3%#14 | 8.6%#13 | 6.7%#14 | — | 14.0%#11 | 6.8%#1 |
| BMY | $133.7B#12 | 14.4x#1 | 6.0x#6 | 2.8x#4 | -0.2%#15 | 178.8%#3 | 21.8%#9 | 31.6%#6 | 14.0%#10 | 7#2 | 53.6%#4 | 3.8%#2 |
| DHR | $138.9B#11 | 35.1x#10 | 2.6x#3 | 5.7x#11 | 2.9%#12 | -7.3%#14 | 19.1%#11 | 6.9%#14 | 5.4%#15 | 5#4 | 0.9%#13 | 0.6%#12 |
| VRTX | $119.4B#15 | 27.9x#5 | 6.2x#7 | 9.9x#14 | 8.9%#7 | 838.1%#2 | 34.8%#2 | 20.4%#9 | 25.4%#2 | — | 1.8%#12 | — |
| SYK | $130.9B#14 | 35.4x#11 | 11.2x#12 | 5.2x#8 | 11.2%#4 | 8.5%#8 | 19.5%#10 | 27.7%#8 | 15.1%#9 | 8#1 | -8.9%#14 | 1.0%#10 |
Peer set: top holdings of XLV (Health Care Select Sector SPDR Fund), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice